Sirolimus Solution
Product Images NDC 69238-1594

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 69238-1594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sirolimus Oral Solution 1)

FDA Label Image

Bottle Label (Sirolimus Oral Solution 10)

Bottle Label (Sirolimus Oral Solution 10)
This is a description of the usage and storage requirements for Sirolimus oral solution, which is used for oral consumption only. It contains 1 mg of Sirolimus per mL and 1.5% to 2.5% ethanol. The medicine should be stored in a refrigerator at 2°C to 8°C and protected from light. The contents should be used within one month of opening. Other components in the solution include propylene glycol, phosphatidylcholine derived from soy lecithin, and polysorbate 80. Pharmacists must dispense the enclosed medication guide to each patient. No additional information is available from the provided text.*
FDA Label Image

Inner Carton (Sirolimus Oral Solution 11)

Inner Carton (Sirolimus Oral Solution 11)
Sirolimus is an oral solution medication that is available in a 60 mL bottle. The recommended dosage is included with the prescribing information that accompanies the solution. The solution should be stored in a refrigerator between 2-8 degrees Celsius and protected from light. The solution should be used within a month of opening. The solution contains 1mg sirolimus per mL, ethanol, and a mixture of propylene glycol, phosphatidylcholine derived from soy lecithin, and polysorbate 80. Amneal Pharmaceuticals LLC distributes the product. Pharmacists are encouraged to dispense the included medication guide to each patient. Keep out of reach of children.*
FDA Label Image

Outer Carton (Sirolimus Oral Solution 12)

Outer Carton (Sirolimus Oral Solution 12)
Sirolimus Oral Solution is a medication that is meant for oral use only. It comes in a 60 mL patient kit which includes an amber glass bottle of sirolimus with a concentration of 1 mg/mL, an instruction guide, and a set of oral syringes and caps for daily dosing. It is recommended to store this medication in a refrigerator between 2-8°C and to protect it from light. This medication should be used within 1 month after opening the bottle. To administer, an oral syringe adapter is fitted into the neck of the bottle and the solution is drawn into a syringe for dosing. It contains a mixture of propylene glycol, ethanol, phosphatidylcholine, and polysorbate 80 and should be kept out of reach of children.*
FDA Label Image

Carton Figure (Sirolimus Oral Solution 2)

FDA Label Image

Figure 1 (Sirolimus Oral Solution 3)

FDA Label Image

Figure 2 (Sirolimus Oral Solution 4)

FDA Label Image

Figure 3 (Sirolimus Oral Solution 5)

FDA Label Image

Figure 4 (Sirolimus Oral Solution 6)

FDA Label Image

Figure 5 (Sirolimus Oral Solution 7)

FDA Label Image

Figure 6 (Sirolimus Oral Solution 8)

FDA Label Image

Figure 7 (Sirolimus Oral Solution 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.